Aging and Cancer

2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1007/978-3-031-27133-5_30
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In this chapter, we will discuss aging as the progressive decline in the function of cells, tissues and organs that leads to impaired functions of our body. Accordingly, older age is the primary risk factor for non-communicative diseases, such as cancer. Common hallmarks of aging are cellular senescence, genome instability, epigenetic alterations and telomere attrition. Interestingly, epigenetic signatures can serve as biomarkers of aging, since the process is associated with specific chromatin patterns and chromatin modifiers that are able to modulate both life- and healthspan. The shortening of telomeres has on one hand a tumor-suppressive effect, since it induces cell cycle arrest, but on the other hand it can also lead to extensive genome instability that promotes cancer progression.